Lenvatinib in Treating Patients With Metastatic or Advanced Pheochromocytoma or Paraganglioma That Cannot Be Removed by Surgery

Clinical trial NCT03008369 · COMPLETED

Trial details

NCT number: NCT03008369
Sponsor: Mayo Clinic
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Malignant Adrenal Gland Pheochromocytoma Malignant Paraganglioma Metastatic Adrenal Gland Pheochromocytoma

Start date: 2017-05-31
Primary completion: 2020-12-01
Enrollment: 3

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.